These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27581218)

  • 1. Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate.
    Bromley RL; Calderbank R; Cheyne CP; Rooney C; Trayner P; Clayton-Smith J; García-Fiñana M; Irwin B; Morrow JI; Shallcross R; Baker GA;
    Neurology; 2016 Nov; 87(18):1943-1953. PubMed ID: 27581218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol.
    Stjerna S; Huber-Mollema Y; Tomson T; Perucca E; Battino D; Craig J; Sabers A; Thomas S; Vajda F; Gaily E
    Epilepsy Behav; 2024 Oct; 159():110024. PubMed ID: 39217754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
    Bjørk MH; Zoega H; Leinonen MK; Cohen JM; Dreier JW; Furu K; Gilhus NE; Gissler M; Hálfdánarson Ó; Igland J; Sun Y; Tomson T; Alvestad S; Christensen J
    JAMA Neurol; 2022 Jul; 79(7):672-681. PubMed ID: 35639399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure.
    Huber-Mollema Y; van Iterson L; Oort FJ; Lindhout D; Rodenburg R
    J Neurol; 2020 Jun; 267(6):1724-1736. PubMed ID: 32112258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
    Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The teratogenicity of the newer antiepileptic drugs - an update.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Acta Neurol Scand; 2014 Oct; 130(4):234-8. PubMed ID: 25040242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
    Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    Lancet Neurol; 2013 Mar; 12(3):244-52. PubMed ID: 23352199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Child development following in utero exposure: levetiracetam vs sodium valproate.
    Shallcross R; Bromley RL; Irwin B; Bonnett LJ; Morrow J; Baker GA; ;
    Neurology; 2011 Jan; 76(4):383-9. PubMed ID: 21263139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.
    Shallcross R; Bromley RL; Cheyne CP; García-Fiñana M; Irwin B; Morrow J; Baker GA; ;
    Neurology; 2014 Jan; 82(3):213-21. PubMed ID: 24401687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
    Bromley R; Adab N; Bluett-Duncan M; Clayton-Smith J; Christensen J; Edwards K; Greenhalgh J; Hill RA; Jackson CF; Khanom S; McGinty RN; Tudur Smith C; Pulman J; Marson AG
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD010224. PubMed ID: 37647086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.
    Meador KJ; Baker GA; Browning N; Clayton-Smith J; Combs-Cantrell DT; Cohen M; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    N Engl J Med; 2009 Apr; 360(16):1597-605. PubMed ID: 19369666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Exposure to Antiseizure Medications and Risk of Epilepsy in Children of Mothers With Epilepsy.
    Dreier JW; Christensen J; Igland J; Gissler M; Leinonen MK; Vegrim HM; Sun Y; Tomson T; Zoega H; Bjørk MH; Bromley RL
    JAMA Netw Open; 2024 Feb; 7(2):e2356425. PubMed ID: 38407908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    J Neurol; 2014 Mar; 261(3):579-88. PubMed ID: 24449062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.
    Baker GA; Bromley RL; Briggs M; Cheyne CP; Cohen MJ; García-Fiñana M; Gummery A; Kneen R; Loring DW; Mawer G; Meador KJ; Shallcross R; Clayton-Smith J;
    Neurology; 2015 Jan; 84(4):382-90. PubMed ID: 25540307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.
    Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    JAMA Pediatr; 2014 Aug; 168(8):729-36. PubMed ID: 24934501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.
    Hernández-Díaz S; Straub L; Bateman BT; Zhu Y; Mogun H; Wisner KL; Gray KJ; Lester B; McDougle CJ; DiCesare E; Pennell PB; Huybrechts KF
    N Engl J Med; 2024 Mar; 390(12):1069-1079. PubMed ID: 38507750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.
    Cohen MJ; Meador KJ; May R; Loblein H; Conrad T; Baker GA; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    Epilepsy Behav; 2019 Mar; 92():154-164. PubMed ID: 30660966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.
    Cohen JM; Alvestad S; Suarez EA; Schaffer A; Selmer RM; Havard A; Bateman BT; Cesta CE; Zoega H; Odsbu I; Huybrechts KF; Kjerpeseth LJ; Straub L; Leinonen MK; Bjørk MH; Nørgaard M; Gissler M; Ulrichsen SP; Hernandez-Diaz S; Tomson T; Furu K
    Neurology; 2024 Jan; 102(2):e207996. PubMed ID: 38165339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.